Clinical Roundup MammaPrint + BluePrint genomic profiling predicts anthracycline chemotherapy benefit in HR+HER2- early-stage breast cancer July 02, 2026Vol.52 No.26
Clinical Roundup Despite overall decline in secondary cancer diagnoses, female lung cancer survivors saw 60% increase from the 1970s to the 2010s, VCU Massey analysis finds July 02, 2026Vol.52 No.26
Clinical Roundup UTSW study shows how RNA-modifying enzyme linked to cancer picks its targets July 02, 2026Vol.52 No.26
Clinical Roundup Thymus may help prepare CD8+ T cells for rapid response before circulation, Mayo study suggests July 02, 2026Vol.52 No.26
Clinical Roundup NYU Langone study sheds light on early respiratory failure in AML July 02, 2026Vol.52 No.26
Clinical Roundup Alliance launches study of immunotherapy to prevent lung cancer recurrence July 02, 2026Vol.52 No.26
Clinical Roundup First patient enrolls in MMRF’s Horizon Two clinical trial for newly diagnosed multiple myeloma treatment July 02, 2026Vol.52 No.26
Clinical Roundup Canine osteosarcoma data highlights growing role of comparative oncology July 02, 2026Vol.52 No.26
Clinical Roundup High patient volume is the leading driver of burnout in cancer and infusion centers, LeanTaaS’s “State of Cancer Centers” 2026 report finds July 02, 2026Vol.52 No.26
